Vijenthira A, Gong IY, Fox TA et al (2020) Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients. Blood 136(25):2881–2892

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ragab D, Salah Eldin H, Taeimah M et al (2020) The COVID-19 cytokine storm; what we know so far. Front Immunol 11:1446

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sharman JP, Biondo JML, Boyer M et al (2022) A review of the incidence of tumor lysis syndrome in patients with chronic lymphocytic leukemia treated with venetoclax and debulking strategies. EJHaem 3(2):492–506

Article  PubMed  PubMed Central  Google Scholar 

Shin DH, Gillard A, Van Wieren A et al (2022) Remission of liquid tumors and SARS-CoV-2 infection: a literature review. Mol Ther Oncolytics 26:135–140

Article  CAS  PubMed  PubMed Central  Google Scholar 

Living guidance for clinical management of COVID-19: living guidance, 23 November 2021—World Health Organization (WHO). WHO/2019-nCoV/clinical/2021.2

Fardet L, Galicier L, Lambotte O et al (2014) Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol 66(9):2613–2620

Article  PubMed  Google Scholar 

Challenor S, Tucker D (2021) SARS-CoV-2-induced remission of Hodgkin lymphoma. Br J Haematol 192(3):415

Article  CAS  PubMed  Google Scholar 

Sollini M, Gelardi F, Carlo-Stella C et al (2021) Complete remission of follicular lymphoma after SARS-CoV-2 infection: from the “flare phenomenon” to the “abscopal effect.” Eur J Nucl Med Mol Imaging 48(8):2652–2654

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yilmaz F, Yasar S, Tuncali MC et al (2021) Complete response in a frail patient with high-grade B-cell lymphoma to only one cycle of R-CHOP or prolonged COVID-19? Semin Oncol 48(4–6):279–282

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kandeel EZ, Refaat L, Abdel-Fatah R et al (2021) Could COVID-19 induce remission of acute leukemia? Hematology 26(1):870–873

Article  CAS  PubMed  Google Scholar 

Barnabei R, Di Michele G, Cellini A et al (2021) Transient disappearance of CD19+/CD5+ B-lymphocyte clone in peripheral blood in a patient with CLL during SARS-CoV-2-related mild disease. Clin Case Rep 9(6):e04238

Article  PubMed  PubMed Central  Google Scholar 

Antwi-Amoabeng D, Ulanja MB, Beutler BD et al (2021) Multiple myeloma remission following COVID-19: an observation in search of a mechanism (a case report). Pan Afr Med J 39:117

PubMed  PubMed Central  Google Scholar 

Barkhordar M, Rostami FT, Yaghmaie M et al (2022) Spontaneous complete remission of acute myeloid leukemia in the absence of disease-modifying therapy following severe pulmonary involvement by coronavirus infectious disease-19. Case Rep Hematol 2022:2603607

PubMed  PubMed Central  Google Scholar 

Kurlapski M, Romanowicz G, Taszner M, Zaucha JM et al (2022) SARS-CoV-2-induced remission of advanced classical Hodgkin lymphoma. Pol Arch Intern Med 132(7–8):16266

PubMed  Google Scholar 

Baptista RL, Moreira R, Rego E (2022) COVID-19 induced follicular lymphoma remission. Hematol Transfus Cell Ther 44(2):291–292

Article  PubMed  PubMed Central  Google Scholar 

Bülbül H, Nazlı HE, Olgun A et al (2022) Spontaneous remission of chronic lymphocytic leukemia in a patient with SARS-CoV2. Leuk Res Rep 18:100336

PubMed  PubMed Central  Google Scholar 

Snowden C, Ng S, Choi J (2022) Partial remission of advanced untreated Sézary syndrome after COVID-19. JAAD Case Rep 21:165–168

Article  PubMed  PubMed Central  Google Scholar 

Ohadi L, Hosseinzadeh F, Dadkhahfar S et al (2022) Oncolytic effect of SARS-CoV-2 in a patient with mycosis fungoides: a case report. Clin Case Rep 10(4):e05682

Article  PubMed  PubMed Central  Google Scholar 

Waseem Hajjar AH, Abbarh S, Al-Mashdali A et al (2022) Tumor lysis syndrome in the chronic phase of chronic myeloid leukemia following COVID-19 infection: a case report. Cureus 14(4):e24386

PubMed  PubMed Central  Google Scholar 

Barh D, Tiwari S, Gabriel Rodrigues Gomes L, Weener ME et al (2021) Potential molecular mechanisms of rare anti-tumor immune response by SARS-CoV-2 in isolated cases of lymphomas. Viruses 13(10):1927

Article  CAS  PubMed  PubMed Central  Google Scholar 

Damle RN, Ghiotto F, Valetto A et al (2002) B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes. Blood 99(11):4087–4093

Article  CAS  PubMed  Google Scholar 

Kosmaczewska A, Ciszak L, Suwalska K et al (2005) CTLA-4 overexpression in CD19+/CD5+ cells correlates with the level of cell cycle regulators and disease progression in B-CLL patients. Leukemia 19(2):301–304

Article  CAS  PubMed  Google Scholar